Seattle Genetics, Inc. (SGEN) financial statements (2020 and earlier)

Company profile

Business Address 21823 30TH DRIVE SE
BOTHELL, WA 98021
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments81141141358965057374
Cash and cash equivalents275781611091025764
Short-term investments536332252480547 310
Receivables2361468562533930
Inventory, net of allowances, customer advances and progress billings86536068574327
Inventory86536068574327
Other undisclosed current assets44431916122686
Total current assets:1,177654577735771408437
Noncurrent Assets
Operating lease, right-of-use asset65
Property, plant and equipment15510410463504641
Long-term investments and receivables5749 3063  
Long-term investments5749 3063  
Intangible assets, net (including goodwill)575575   34
Goodwill275275     
Intangible assets, net (excluding goodwill)300300   34
Other noncurrent assets177122197111156
Other undisclosed noncurrent assets     (3)(4)
Total noncurrent assets:1,0298503011041245147
TOTAL ASSETS:2,2061,503878838895459484
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:259191133121887878
Accounts payable524429292117 
Accrued liabilities207147     
Employee-related liabilities  3830252218
Accounts payable and other accrued liabilities59
Other undisclosed accounts payable and accrued liabilities  65624238 
Deferred revenue and credits3428464840
Contract with customer, liability34
Other liabilities     32
Other undisclosed current liabilities     (3)(20)
Total current liabilities:25922516714913412699
Noncurrent Liabilities
Long-term debt and lease obligation68      
Operating lease, liability68
Liabilities, other than long-term debt34315371118149
Deferred revenue and credits315371118149
Other liabilities34     
Other undisclosed noncurrent liabilities  33455
Total noncurrent liabilities:704335675122155
Total liabilities:330229200204209248254
Stockholders' equity
Stockholders' equity attributable to parent1,8761,274678634686211230
Common stock0000000
Additional paid in capital3,3592,5981,8061,7011,6131,017960
Accumulated other comprehensive income (loss)0(0)64(0)(1)(0)(0)
Accumulated deficit(1,483)(1,325)(1,193)(1,067)(927)(806)(730)
Total stockholders' equity:1,8761,274678634686211230
TOTAL LIABILITIES AND EQUITY:2,2061,503878838895459484

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues917655482418337287269
Revenue, net482418337287269
Cost of revenue(18)(63)(35)(42)(37)(18)(14)
Cost of goods and services sold (18)(35)(28)(24)(18)(14)
Gross profit:898592447376299269256
Operating expenses(1,119)(852)(643)(519)(420)(347)(319)
Other undisclosed operating income     00
Operating loss:(221)(260)(196)(143)(121)(77)(63)
Nonoperating income
(Investment Income, Nonoperating)
126373010
Other undisclosed income from continuing operations before equity method investments, income taxes507     
Loss from continuing operations before income taxes:(159)(246)(159)(140)(120)(76)(63)
Income tax benefit 2433    
Net loss available to common stockholders, diluted:(159)(223)(126)(140)(120)(76)(63)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(159)(223)(126)(140)(120)(76)(63)
Other comprehensive income (loss)00641(1)  
Comprehensive loss:(158)(222)(62)(139)(121)(76)(63)
Other undisclosed comprehensive loss, net of tax, attributable to parent     (0)(0)
Comprehensive loss, net of tax, attributable to parent:(158)(222)(62)(139)(121)(76)(63)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: